Ownership history in Man Group plc · 16 quarters on record
This page tracks every 13F SEC filing in which Man Group plc reported a position in VIR BIOTECHNOLOGY INC (VIR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 70,477 | -186,441 | -72.6% | 0.00% | $402K | $5.71 |
| 2025 Q2 | ADDED | 256,918 | +164,727 | +178.7% | 0.00% | $1.3M | $5.04 |
| 2025 Q1 | ADDED | 92,191 | +78,593 | +578.0% | 0.00% | $597K | $6.48 |
| 2023 Q3 | REDUCED | 13,598 | -283,929 | -95.4% | 0.00% | $127K | $9.37 |
| 2023 Q2 | REDUCED | 297,527 | -31,494 | -9.6% | 0.02% | $7.3M | $24.53 |
| 2023 Q1 | ADDED | 329,021 | +261,677 | +388.6% | 0.03% | $7.7M | $23.27 |
| 2022 Q4 | REDUCED | 67,344 | -93,895 | -58.2% | 0.01% | $1.7M | $25.31 |
| 2022 Q3 | REDUCED | 161,239 | -175,087 | -52.1% | 0.01% | $3.1M | $19.28 |
| 2022 Q2 | ADDED | 336,326 | +169,935 | +102.1% | 0.04% | $8.6M | $25.47 |
| 2022 Q1 | ADDED | 166,391 | +109,637 | +193.2% | 0.01% | $4.3M | $25.72 |
As of 2025 Q4 — sorted by position size